HEADER MOTOR PROTEIN 20-JUL-18 6E5N TITLE SOLUTION STRUCTURE OF HUMAN MYOSIN VI ISOFORM 3 (1050-1131) IN COMPLEX TITLE 2 WITH CLATHRIN LIGHT CHAIN A (46-61) COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCONVENTIONAL MYOSIN-VI; COMPND 3 CHAIN: B; COMPND 4 SYNONYM: UNCONVENTIONAL MYOSIN-6; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CLATHRIN LIGHT CHAIN A; COMPND 8 CHAIN: A; COMPND 9 SYNONYM: LCA; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MYO6, KIAA0389; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CLTA; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MYOSIN, CLATHRIN, TRAFFICKING, ENDOCYTOSIS, MOTOR PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.R.BUEL,K.J.WALTERS REVDAT 3 14-JUN-23 6E5N 1 REMARK REVDAT 2 03-JUN-20 6E5N 1 JRNL REVDAT 1 20-NOV-19 6E5N 0 JRNL AUTH M.BIANCOSPINO,G.R.BUEL,C.A.NINO,E.MASPERO, JRNL AUTH 2 R.SCOTTO DI PERROTOLO,A.RAIMONDI,L.REDLINGSHOFER,J.WEBER, JRNL AUTH 3 F.M.BRODSKY,K.J.WALTERS,S.POLO JRNL TITL CLATHRIN LIGHT CHAIN A DRIVES SELECTIVE MYOSIN VI JRNL TITL 2 RECRUITMENT TO CLATHRIN-COATED PITS UNDER MEMBRANE TENSION. JRNL REF NAT COMMUN V. 10 4974 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 31672988 JRNL DOI 10.1038/S41467-019-12855-6 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6E5N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1000235583. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283.2 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 MM NACL, 20 MM NAPO4 REMARK 210 PRESSURE : 760 MMHG REMARK 210 SAMPLE CONTENTS : 0.36 MM [U-13C; U-15N] MYOSIN VI REMARK 210 1050-1131, 0.36 MM NONE CLATHRIN REMARK 210 LIGHT CHAIN ALPHA 46-61, 95% H2O/ REMARK 210 5% D2O; 0.4 MM NONE MYOSIN VI REMARK 210 1050-1131, 0.4 MM [U-13C; U-15N] REMARK 210 CLATHRIN LIGHT CHAIN ALPHA 46-61, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D 1H-15N NOESY; REMARK 210 2D 1H-13C HSQC; 3D 1H-13C NOESY; REMARK 210 3D HNCO; 3D HNCACB; HALF- REMARK 210 FILTERED 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 850 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, NMRDRAW, REMARK 210 XEASY, TALOS, X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 GLY B 1045 REMARK 465 PRO B 1046 REMARK 465 LEU B 1047 REMARK 465 GLY B 1048 REMARK 465 SER B 1049 REMARK 465 GLY A 38 REMARK 465 PRO A 39 REMARK 465 LEU A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 PRO A 43 REMARK 465 GLU A 44 REMARK 465 PHE A 45 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 56 -61.36 -148.78 REMARK 500 2 ALA B1078 109.87 171.50 REMARK 500 2 ALA B1079 -79.39 -63.30 REMARK 500 2 ASP A 56 -62.21 -144.40 REMARK 500 3 ASP A 56 -62.97 -150.94 REMARK 500 4 LYS B1082 33.91 -89.93 REMARK 500 4 ASP A 56 -61.45 -144.77 REMARK 500 5 ALA B1071 72.90 48.06 REMARK 500 5 ASP A 56 -62.05 -147.44 REMARK 500 6 VAL B1072 19.77 58.89 REMARK 500 6 ASP A 56 -62.62 -150.92 REMARK 500 7 LYS B1052 -65.00 -123.18 REMARK 500 7 ALA B1077 -66.08 -159.87 REMARK 500 7 ALA B1078 82.23 53.18 REMARK 500 7 ASP A 56 -61.82 -150.71 REMARK 500 8 ALA B1071 90.59 47.34 REMARK 500 8 LEU B1073 40.09 -107.94 REMARK 500 8 ASP A 56 -62.08 -150.31 REMARK 500 9 LYS B1129 -61.04 -123.76 REMARK 500 9 ASP A 56 -60.58 -150.23 REMARK 500 10 ASP A 56 -62.16 -149.74 REMARK 500 11 LYS B1129 -62.58 -127.33 REMARK 500 11 ASP A 56 -61.39 -144.34 REMARK 500 12 ALA B1079 117.94 -166.05 REMARK 500 12 ASP A 56 -61.87 -150.47 REMARK 500 13 ALA B1071 27.66 -177.80 REMARK 500 13 ASP A 56 -63.65 -151.60 REMARK 500 14 ALA B1078 -80.74 -72.93 REMARK 500 14 ALA B1079 -179.31 176.00 REMARK 500 14 ASP A 56 -62.79 -144.17 REMARK 500 15 ALA B1074 28.52 47.96 REMARK 500 15 LYS B1129 -63.86 -127.50 REMARK 500 15 ASP A 56 -62.14 -147.67 REMARK 500 16 ASP A 56 -61.92 -156.91 REMARK 500 17 ASP A 56 -63.26 -148.90 REMARK 500 18 LYS B1052 -64.39 -122.66 REMARK 500 18 LEU B1073 19.05 57.47 REMARK 500 18 THR B1075 -31.12 -130.67 REMARK 500 18 ASP A 56 -61.42 -143.98 REMARK 500 19 LYS B1082 -75.00 -119.64 REMARK 500 19 ASP A 56 -61.29 -155.69 REMARK 500 20 ALA B1078 27.69 48.47 REMARK 500 20 ASP A 56 -61.68 -149.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30500 RELATED DB: BMRB REMARK 900 STRUCTURE OF A PROTEIN COMPLEX DBREF 6E5N B 1050 1131 UNP Q9UM54 MYO6_HUMAN 1041 1122 DBREF 6E5N A 46 61 UNP P09496 CLCA_HUMAN 46 61 SEQADV 6E5N GLY B 1045 UNP Q9UM54 EXPRESSION TAG SEQADV 6E5N PRO B 1046 UNP Q9UM54 EXPRESSION TAG SEQADV 6E5N LEU B 1047 UNP Q9UM54 EXPRESSION TAG SEQADV 6E5N GLY B 1048 UNP Q9UM54 EXPRESSION TAG SEQADV 6E5N SER B 1049 UNP Q9UM54 EXPRESSION TAG SEQADV 6E5N GLY A 38 UNP P09496 EXPRESSION TAG SEQADV 6E5N PRO A 39 UNP P09496 EXPRESSION TAG SEQADV 6E5N LEU A 40 UNP P09496 EXPRESSION TAG SEQADV 6E5N GLY A 41 UNP P09496 EXPRESSION TAG SEQADV 6E5N SER A 42 UNP P09496 EXPRESSION TAG SEQADV 6E5N PRO A 43 UNP P09496 EXPRESSION TAG SEQADV 6E5N GLU A 44 UNP P09496 EXPRESSION TAG SEQADV 6E5N PHE A 45 UNP P09496 EXPRESSION TAG SEQRES 1 B 87 GLY PRO LEU GLY SER ARG PRO LYS MET THR PRO GLU GLN SEQRES 2 B 87 MET ALA LYS GLU MET SER GLU PHE LEU SER ARG GLY PRO SEQRES 3 B 87 ALA VAL LEU ALA THR LYS ALA ALA ALA GLY THR LYS LYS SEQRES 4 B 87 TYR ASP LEU SER LYS TRP LYS TYR ALA GLU LEU ARG ASP SEQRES 5 B 87 THR ILE ASN THR SER CYS ASP ILE GLU LEU LEU ALA ALA SEQRES 6 B 87 CYS ARG GLU GLU PHE HIS ARG ARG LEU LYS VAL TYR HIS SEQRES 7 B 87 ALA TRP LYS SER LYS ASN LYS LYS ARG SEQRES 1 A 24 GLY PRO LEU GLY SER PRO GLU PHE ILE GLU ASN ASP GLU SEQRES 2 A 24 ALA PHE ALA ILE LEU ASP GLY GLY ALA PRO GLY HELIX 1 AA1 THR B 1054 GLY B 1069 1 16 HELIX 2 AA2 THR B 1075 ALA B 1079 5 5 HELIX 3 AA3 LYS B 1090 SER B 1101 1 12 HELIX 4 AA4 ASP B 1103 LYS B 1130 1 28 HELIX 5 AA5 GLU A 47 LEU A 55 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1